Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Harpoon Therapeutics Inc.
Harpoon Therapeutics Strengthens Leadership Team
December 26, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium
December 19, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)
December 11, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition
November 02, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Announces Up to $150 Million Private Placement
October 23, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Announces Updated Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
October 21, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023
October 16, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
October 09, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting
September 28, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort
September 15, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Provides an Update on the HPN217 Development and Option Agreement with AbbVie
September 13, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Abstract for HPN217 Accepted for Poster Presentation at the 20th International Myeloma Society Annual Meeting
September 06, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023
September 05, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 09, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August
August 03, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development
August 01, 2023
From
Harpoon Therapeutics Inc.
Via
GlobeNewswire
Tickers
HARP
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.